Category Atopic Dermatitis

Dupilumab — TrialistMD Drug Profile TRIALISTMD · DRUG INTELLIGENCE DERMATOLOGY IL-4Rα Antagonist · Monoclonal Antibody · BLA 761055 dupilumab DUPIXENT® Recombinant fully human IgG4 monoclonal antibody targeting the IL-4Rα subunit, blocking both IL-4 and IL-13 signaling via Type I and…

Lebrikizumab (EBGLYSS) — Drug Profile | TrialistMD TRIALISTMD.COM DRUG PROFILE Anti-IL-13 Monoclonal Antibody · Type 2 Biologic · Atopic Dermatitis lebrikizumab EBGLYSS® · Eli Lilly and Company An IgG4 monoclonal antibody that binds IL-13 with high affinity and slow off-rate,…

Tralokinumab (ADBRY) — Drug Profile | TrialistMD TRIALISTMD.COM DRUG PROFILE IL-13 Antagonist · IgG4 mAb · Dermatology · Atopic Dermatitis Tralokinumab-ldrm ADBRY™  ·  LEO Pharma A/S A fully human IgG4 monoclonal antibody that selectively neutralizes interleukin-13 (IL-13), a key Th2…

Abrocitinib (CIBINQO) — Drug Profile | TrialistMD TRIALISTMD.COM DRUG PROFILE JAK1 Inhibitor (Selective) · Small Molecule · Dermatology Abrocitinib CIBINQO™ · Pfizer Labs, Division of Pfizer Inc. A selective, reversible JAK1 inhibitor that blocks the ATP binding site at JAK1…

Delgocitinib (ANZUPGO) — Drug Profile | TrialistMD TRIALISTMD.COM DRUG PROFILE JAK Inhibitor (Pan-JAK) · Small Molecule · Dermatology Delgocitinib ANZUPGO® · 2% cream (20 mg/g) First-in-class topical pan-JAK inhibitor (JAK1/2/3/TYK2) approved for moderate to severe chronic hand eczema (CHE) in…

Difamilast (ADQUEY) — Drug Profile | TrialistMD TRIALISTMD.COM DRUG PROFILE PDE-4 Inhibitor · Topical Small Molecule · Dermatology Difamilast ADQUEY™ · Acrotech Biopharma Inc. A selective topical phosphodiesterase-4 (PDE-4) inhibitor indicated for the topical treatment of adults and pediatric patients…